ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression

Molecular Endocrinology

Volumn 26, Issue 9, 2012, Pages 1567-1577

  Sun, Jun ^a   Zhou, Wen ^a   Kaliappan, Kosalai ^a   Nawaz, Zafar ^a   Slingerland, Joyce M ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E6 ASSOCIATED PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROTEIN TYROSINE KINASE; TYROSINE; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; HUMANS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SRC-FAMILY KINASES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84865598603     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1140     Document Type: Article

References (67)

1. Nilsson S, Gustafsson JA 2002 Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37:1-28
2. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P 1986 Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24:77-83
3. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J 1986 Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154
4. Mosselman S, Polman J, Dijkema R 1996 ER β: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
5. Lonard DM, O'Malley BW 2007 Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27:691-700
6. Reid G, Denger S, Kos M, Gannon F 2002 Human estrogen recep-tor-a: regulation by synthesis, modification and degradation. Cell Mol Life Sci 59:821-831
7. Horigome T, Ogata F, Golding TS, Korach KS 1988 Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus. Endocrinology 123:2540-2548
8. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862
9. Wijayaratne AL, McDonnell DP 2001 The human estrogen recep-tor-a is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684-35692
10. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW 1999 The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19:1182-1189
11. Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S, Hayashi S 2001 MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem Bio-phys Res Commun 281:259-265
12. Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, Rosen EM 1999 BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284: 1354-1356
13. Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM 2001 Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 98:5134-5139
14. Verma S, Ismail A, Gao X, Fu G, Li X, O'Malley BW, Nawaz Z 2004 The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol Cell Biol 24:8716-8726
15. Gottlicher M, Heck S, Doucas V, Wade E, Kullmann M, Cato AC, Evans RM, Herrlich P 1996 Interaction of the Ubc9 human homo-logue with c-Jun and with the glucocorticoid receptor. Steroids 61:257-262
16. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Janne OA 1999 Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 274:19441-19446
17. vom Baur E, Zechel C, Heery D, Heine MJ, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R 1996 Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124
18. Shao W, Keeton EK, McDonnell DP, Brown M 2004 Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci USA 101:11599-11604
19. Reid G, Hiibner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-me-diated turnover of unliganded and liganded ERa on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707
20. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-a and coactivator turnover and for efficient estrogen receptor-a transactivation. Mol Cell 5:939-948
21. Weissman AM 2001 Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169-178
22. Glickman MH, Ciechanover A 2002 The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428
23. Joazeiro CA, Weissman AM 2000 RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549-552
24. Cardozo T, Pagano M 2004 The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 5:739-751
25. Lange CA, Shen T, Horwitz KB 2000 Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97:1032-1037
26. Chymkowitch P, Le May N, Charneau P, Compe E, Egly JM 2011 The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J 30:468-479
27. Thomas SM, Brugge JS 1997 Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609
28. Belsches-Jablonski AP, Biscardi JS, Peavy DR, Tice DA, Romney DA, Parsons SJ 2001 Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene 20:14651475
29. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinas/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells. EMBO J 15:1292-1300
30. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F 1998 Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008-2018
31. Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA 1986 Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261:13754-13759
32. Frame MC 2002 Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602:114-130
33. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE 1992 Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52:4773-4778
34. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J 2007 p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128:281-294
35. Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C, Chun K, Hennessy B, Mills GB, Nawaz Z, Slingerland JM 2007 Src promotes estrogen-dependent estrogen receptor a proteolysis in human breast cancer. J Clin Invest 117:2205-2215
36. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS 1994 Phosphorylation of the human estrogen receptor. J Biol Chem 269: 4458-4466
37. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H 2001 Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor a: a new model for anti-estrogen resistance. J Biol Chem 276:9817-9824
38. Rayala SK, Talukder AH, Balasenthil S, Tharakan R, Barnes CJ, Wang RA, Aldaz CM, Khan S, Kumar R 2006 P21-activated kinase 1 regulation of estrogen receptor-a activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res 66: 1694-1701
39. Arnold SF, Obourn JD, Jaffe H, Notides AC 1995 Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol Endocrinol 9:24-33
40. Likhite VS, Stossi F, Kim K, Katzenellenbogen BS, Katzenellenbo-gen JA 2006 Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, DNA, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol Endocrinol 20:3120-3132
41. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521
42. Ramamoorthy S, Dhananjayan SC, Demayo FJ, Nawaz Z 2010 Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. Mol Endocrinol 24:2099-2113
43. Sun J, Nawaz Z, Slingerland JM 2007 Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen responsive elements in breast cancer cells. Mol Endocrinol 21: 2651-2662
44. Tansey WP 2001 Transcriptional activation: risky business. Genes Dev 15:1045-1050
45. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP 2001 Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651-1653
46. Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, Miyazono K 2001 Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell 12:1431-1443
47. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, Cheng SY 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990
48. Shen T, Horwitz KB, Lange CA 2001 Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21:6122-6131
49. Nawaz Z, O'Malley BW 2004 Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18:493-499
50. Fan M, Nakshatri H, Nephew KP 2004 Inhibiting proteasomal proteolysis sustains estrogen receptor-a activation. Mol Endocrinol 18:2603-2615
51. Arnold SF, ObournJD, Jaffe H, Notides AC 1994 Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol Endocrinol 8:1208-1214
52. Ali S, Metzger D, Bornert JM, Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12:1153-1160
53. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494.
54. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:45034511
55. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20:6050-6059
56. He M, Mangiameli DP, Kachala S, Hunter K, Gillespie J, Bian X, Shen HC, Libutti SK 2010 Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival. Clin Cancer Res 16:249-259
57. Durek P, Schudoma C, Weckwerth W, Selbig J, Walther D 2009 Detection and characterization of 3D-signature phosphorylation site motifs and their contribution towards improved phosphorylation site prediction in proteins. BMC Bioinformatics 10:117
58. Li L, Neaves WB 2006 Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66:4553-4557
59. Eakin CM, Maccoss MJ, Finney GL, Klevit RE 2007 Estrogen receptor a is a putative substrate for the BRCA1 ubiquitin ligase. Proc Natl Acad Sci USA 104:5794-5799
60. Dizin E, Irminger-Finger 12010 Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor a stability and activity antagonized by cancer-associated isoform of BARD1. Int J Biochem Cell Biol 42:693-700
61. Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS 1996 Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol 10:1388-1398
62. Tremblay GB, Tremblay A, Labrie F, Gigufre V 1998 Ligand-independent activation of the estrogen receptors a and β by mutations of a conserved tyrosine can be abolished by antiestrogens. Cancer Res 58:877-881
63. Qiu M, Lange CA 2003 MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J Steroid Biochem Mol Biol 85:147157
64. Alarid ET, Preisler-Mashek MT, Solodin NM 2003 Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-a protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144:3469-3476
65. Nirmala PB, Thampan RV 1995 Ubiquitination of the rat uterine estrogen receptor: Dependence on estradiol. Biochem Biophys Res Commun 213:24-31
66. Yan F, Gao X, Lonard DM, Nawaz Z 2003 Specific Ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators. Mol Endocrinol 17:1315-1331
67. Zhang H, Sun L, Liang J, Yu W, Zhang Y, Wang Y, Chen Y, Li R, Sun X, Shang Y 2006 The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J 25:4223-4233